Heparin and heparan sulfate proteoglycans (HSPG) bind many soluble growth f
actors and this binding is now recognized as an important mechanism for mod
ulation of cell activity. Fibroblast growth factor-2 (FGF-2) is one of the
best characterized of the heparin-binding growth factors and it has been sh
own experimentally that heparin regulation of FGF-2 activity is dependent o
n the level of cell HSPG and the concentration of heparin. fn this paper, w
e explore, using mathematical modeling, proposed mechanisms for heparin reg
ulation and determine how they impact FGF receptor binding. We demonstrate
that the experimentally observed receptor binding phenomena can be reproduc
ed if cells (1) express heparin-binding cell surface molecules and if eithe
r (2) these heparin binding sites are FGFR and bind heparin and FGF-2-hepar
in complexes or (3) are surface molecules able to bind FGF-2 and couple wit
h FGF-2 receptors to form high-affinity FGF-2-bound surface complexes. The
ability of heparin to directly interact with the FGFR and bind FGF-2 in the
absence of this coupling function was not sufficient to explain heparin ac
tivity. These findings have implications with regard to regulation of hepar
in-binding growth factors and could help guide the development of highly sp
ecific growth regulatory molecules through specific regulation by heparin a
nd HSPG. (C) 2000 Academic Press.